SCHEMBL5074261

SCHEMBL5074261

ClC1C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354634 0.94
SCHEMBL11335821 0.80
SCHEMBL31484759 0.80
SCHEMBL27922799 0.76
SCHEMBL4350602 0.73
SCHEMBL27383258 0.72
SCHEMBL6048993 0.67
SCHEMBL433010 0.57
Lindane SCHEMBL8110265 0.51 LMNA (1.00)
SCHEMBL8406626 0.51 LMNA (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8981126-B2 Cyclopropenylidene-stabilized phosphenium cations Studiengesellshaft Kohle mbH (DE) 2015-03-17 US disclosed
US-20140288323-A1 CYCLOPROPENIMINE CATALYST COMPOSITIONS AND PROCESSES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-09-25 US disclosed
US-20140051870-A1 CYCLOPROPENYLIDENE-STABILIZED PHOSPHENIUM CATIONS STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2014-02-20 US disclosed
WO-2013059118-A1 CYCLOPROPENIMINE CATALYST COMPOSITIONS AND PROCESSES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-04-25 WO disclosed
US-20080269525-A1 SYNTHESIS OF STABLE CYCLOPROPENYLIDENES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-10-30 US disclosed
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed